Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Sales | 4,663 | 2,227 | 2,033 | 0 | 0 |
| Cost of Goods | N/A | 2,227 | 2,033 | 0 | 0 |
| Gross Profit | 4,663 | 0 | 0 | 0 | 0 |
| Operating Expenses | 0 | 2,152 | 958 | 512 | 374 |
| Operating Income | 4,663 | -1,925 | -925 | -512 | -374 |
| Other Income | 0 | 31 | 0 | 0 | 0 |
| Pre-tax Income | 4,663 | -1,894 | -924 | -512 | -374 |
| Income Tax | N/A | -275 | -191 | -113 | -62 |
| Net Income Continuous | -1,440 | -1,619 | -734 | -399 | -312 |
| Net Income Discontinuous | 0 | 0 | 0 | 0 | -5,335 |
| Net Income | $-1,440 | $-1,619 | $-734 | $-399 | $-5,647 |
| EPS Basic Total Ops | -0.45 | -0.51 | -733.70 | -399.00 | N/A |
| EPS Basic Continuous Ops | -0.45 | -0.51 | -733.70 | -399.00 | N/A |
| EPS Diluted Total Ops | -0.45 | -0.51 | -733.70 | -399.00 | N/A |
| EPS Diluted Continuous Ops | -0.45 | -0.51 | -733.70 | -399.00 | N/A |
| EBITDA(a) | $4,663 | $-1,616 | $-788 | $-353 | $-206 |